nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—HTR3A—autistic disorder	0.388	0.473	CbGaD
Tapentadol—OPRM1—autistic disorder	0.279	0.34	CbGaD
Tapentadol—SLC6A4—autistic disorder	0.154	0.187	CbGaD
Tapentadol—OPRM1—telencephalic ventricle—autistic disorder	0.00549	0.0906	CbGeAlD
Tapentadol—SLC6A4—hindbrain—autistic disorder	0.00215	0.0356	CbGeAlD
Tapentadol—OPRD1—forebrain—autistic disorder	0.0021	0.0347	CbGeAlD
Tapentadol—OPRK1—forebrain—autistic disorder	0.00201	0.0333	CbGeAlD
Tapentadol—OPRD1—telencephalon—autistic disorder	0.00193	0.0319	CbGeAlD
Tapentadol—UGT1A9—digestive system—autistic disorder	0.00187	0.0308	CbGeAlD
Tapentadol—HTR3A—brainstem—autistic disorder	0.00162	0.0267	CbGeAlD
Tapentadol—HTR3A—forebrain—autistic disorder	0.00156	0.0258	CbGeAlD
Tapentadol—UGT2B7—digestive system—autistic disorder	0.0015	0.0248	CbGeAlD
Tapentadol—OPRM1—brainstem—autistic disorder	0.00148	0.0245	CbGeAlD
Tapentadol—HTR3A—telencephalon—autistic disorder	0.00144	0.0237	CbGeAlD
Tapentadol—OPRM1—forebrain—autistic disorder	0.00143	0.0237	CbGeAlD
Tapentadol—OPRM1—telencephalon—autistic disorder	0.00132	0.0218	CbGeAlD
Tapentadol—SLC6A4—brainstem—autistic disorder	0.00123	0.0204	CbGeAlD
Tapentadol—OPRD1—head—autistic disorder	0.0012	0.0199	CbGeAlD
Tapentadol—SLC6A4—forebrain—autistic disorder	0.00119	0.0197	CbGeAlD
Tapentadol—OPRK1—head—autistic disorder	0.00115	0.0191	CbGeAlD
Tapentadol—OPRD1—nervous system—autistic disorder	0.00114	0.0188	CbGeAlD
Tapentadol—OPRD1—central nervous system—autistic disorder	0.0011	0.0181	CbGeAlD
Tapentadol—HTR3A—digestive system—autistic disorder	0.0011	0.0181	CbGeAlD
Tapentadol—SLC6A4—telencephalon—autistic disorder	0.0011	0.0181	CbGeAlD
Tapentadol—OPRK1—nervous system—autistic disorder	0.00109	0.0181	CbGeAlD
Tapentadol—SLC6A2—brainstem—autistic disorder	0.00109	0.018	CbGeAlD
Tapentadol—Phenylephrine—MAOA—autistic disorder	0.00106	1	CrCbGaD
Tapentadol—OPRK1—central nervous system—autistic disorder	0.00105	0.0174	CbGeAlD
Tapentadol—SLC6A2—forebrain—autistic disorder	0.00105	0.0173	CbGeAlD
Tapentadol—CYP2D6—hindbrain—autistic disorder	0.00104	0.0172	CbGeAlD
Tapentadol—OPRK1—cerebellum—autistic disorder	0.00103	0.017	CbGeAlD
Tapentadol—SLC6A2—telencephalon—autistic disorder	0.000965	0.0159	CbGeAlD
Tapentadol—HTR3A—head—autistic disorder	0.000895	0.0148	CbGeAlD
Tapentadol—OPRD1—brain—autistic disorder	0.000872	0.0144	CbGeAlD
Tapentadol—HTR3A—nervous system—autistic disorder	0.000848	0.014	CbGeAlD
Tapentadol—SLC6A4—digestive system—autistic disorder	0.000836	0.0138	CbGeAlD
Tapentadol—OPRK1—brain—autistic disorder	0.000836	0.0138	CbGeAlD
Tapentadol—OPRM1—head—autistic disorder	0.00082	0.0136	CbGeAlD
Tapentadol—HTR3A—central nervous system—autistic disorder	0.000817	0.0135	CbGeAlD
Tapentadol—OPRM1—nervous system—autistic disorder	0.000778	0.0128	CbGeAlD
Tapentadol—OPRM1—central nervous system—autistic disorder	0.000749	0.0124	CbGeAlD
Tapentadol—CYP2C19—digestive system—autistic disorder	0.000693	0.0114	CbGeAlD
Tapentadol—SLC6A4—head—autistic disorder	0.000682	0.0113	CbGeAlD
Tapentadol—HTR3A—brain—autistic disorder	0.000648	0.0107	CbGeAlD
Tapentadol—SLC6A4—nervous system—autistic disorder	0.000647	0.0107	CbGeAlD
Tapentadol—SLC6A4—central nervous system—autistic disorder	0.000623	0.0103	CbGeAlD
Tapentadol—SLC6A2—head—autistic disorder	0.000601	0.00992	CbGeAlD
Tapentadol—CYP2D6—brainstem—autistic disorder	0.000595	0.00983	CbGeAlD
Tapentadol—OPRM1—brain—autistic disorder	0.000595	0.00982	CbGeAlD
Tapentadol—CYP2D6—forebrain—autistic disorder	0.000574	0.00949	CbGeAlD
Tapentadol—SLC6A2—nervous system—autistic disorder	0.00057	0.00941	CbGeAlD
Tapentadol—SLC6A2—central nervous system—autistic disorder	0.000548	0.00906	CbGeAlD
Tapentadol—CYP2C9—digestive system—autistic disorder	0.000537	0.00888	CbGeAlD
Tapentadol—CYP2D6—telencephalon—autistic disorder	0.000528	0.00873	CbGeAlD
Tapentadol—SLC6A4—brain—autistic disorder	0.000494	0.00817	CbGeAlD
Tapentadol—SLC6A2—brain—autistic disorder	0.000435	0.00719	CbGeAlD
Tapentadol—CYP2D6—digestive system—autistic disorder	0.000403	0.00666	CbGeAlD
Tapentadol—CYP2D6—head—autistic disorder	0.000329	0.00543	CbGeAlD
Tapentadol—CYP2D6—nervous system—autistic disorder	0.000312	0.00515	CbGeAlD
Tapentadol—CYP2D6—central nervous system—autistic disorder	0.0003	0.00496	CbGeAlD
Tapentadol—CYP2D6—cerebellum—autistic disorder	0.000293	0.00485	CbGeAlD
Tapentadol—CYP2D6—brain—autistic disorder	0.000238	0.00394	CbGeAlD
Tapentadol—UGT2B7—Metabolism—CYP19A1—autistic disorder	1.78e-05	0.000151	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—PRKCB—autistic disorder	1.72e-05	0.000146	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TSC1—autistic disorder	1.72e-05	0.000145	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—DRD1—autistic disorder	1.72e-05	0.000145	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SLC25A12—autistic disorder	1.71e-05	0.000144	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—PIK3CG—autistic disorder	1.71e-05	0.000144	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PLA2G4A—autistic disorder	1.7e-05	0.000144	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ASMT—autistic disorder	1.67e-05	0.000141	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GSTM5—autistic disorder	1.67e-05	0.000141	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NTRK2—autistic disorder	1.67e-05	0.000141	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—DRD3—autistic disorder	1.66e-05	0.000141	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SLC19A1—autistic disorder	1.66e-05	0.000141	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HTR2A—autistic disorder	1.66e-05	0.00014	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ASMT—autistic disorder	1.66e-05	0.00014	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GSTM5—autistic disorder	1.66e-05	0.00014	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—COMT—autistic disorder	1.66e-05	0.00014	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—PIK3CG—autistic disorder	1.65e-05	0.000139	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GSTP1—autistic disorder	1.65e-05	0.000139	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—MAOA—autistic disorder	1.64e-05	0.000139	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL5—autistic disorder	1.63e-05	0.000138	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—POMC—autistic disorder	1.63e-05	0.000137	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PRL—autistic disorder	1.62e-05	0.000137	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GZMB—autistic disorder	1.61e-05	0.000136	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CALCA—autistic disorder	1.61e-05	0.000136	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CAT—autistic disorder	1.6e-05	0.000136	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SLC25A12—autistic disorder	1.57e-05	0.000133	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—POMC—autistic disorder	1.57e-05	0.000133	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PRKCB—autistic disorder	1.56e-05	0.000132	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR1B—autistic disorder	1.56e-05	0.000132	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—OXT—autistic disorder	1.56e-05	0.000132	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SLC25A12—autistic disorder	1.56e-05	0.000132	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.56e-05	0.000132	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ADRB2—autistic disorder	1.54e-05	0.00013	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SLC19A1—autistic disorder	1.53e-05	0.000129	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	1.53e-05	0.000129	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SLC19A1—autistic disorder	1.52e-05	0.000128	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GSTM1—autistic disorder	1.51e-05	0.000128	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PLA2G4A—autistic disorder	1.51e-05	0.000128	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HTR2A—autistic disorder	1.51e-05	0.000127	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PIK3CG—autistic disorder	1.5e-05	0.000127	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ADSL—autistic disorder	1.48e-05	0.000125	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—PRKCB—autistic disorder	1.46e-05	0.000123	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—XDH—autistic disorder	1.45e-05	0.000123	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TSC1—autistic disorder	1.45e-05	0.000123	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—DRD1—autistic disorder	1.45e-05	0.000123	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GPX1—autistic disorder	1.45e-05	0.000123	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CYP19A1—autistic disorder	1.45e-05	0.000122	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—AVP—autistic disorder	1.44e-05	0.000122	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IGF2—autistic disorder	1.44e-05	0.000122	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—STX1A—autistic disorder	1.43e-05	0.000121	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NPAS2—autistic disorder	1.43e-05	0.000121	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—POMC—autistic disorder	1.42e-05	0.00012	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PRL—autistic disorder	1.42e-05	0.00012	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NTRK2—autistic disorder	1.41e-05	0.000119	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—DRD3—autistic disorder	1.41e-05	0.000119	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—PIK3CG—autistic disorder	1.39e-05	0.000118	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	1.39e-05	0.000118	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TCN2—autistic disorder	1.38e-05	0.000116	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL5—autistic disorder	1.38e-05	0.000116	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ADSL—autistic disorder	1.36e-05	0.000115	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CALCA—autistic disorder	1.36e-05	0.000115	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.36e-05	0.000115	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PLA2G4A—autistic disorder	1.36e-05	0.000115	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ADSL—autistic disorder	1.35e-05	0.000114	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ADRB2—autistic disorder	1.35e-05	0.000114	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—COMT—autistic disorder	1.35e-05	0.000114	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GSTP1—autistic disorder	1.34e-05	0.000113	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—MTHFR—autistic disorder	1.34e-05	0.000113	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—XDH—autistic disorder	1.34e-05	0.000113	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—MAOA—autistic disorder	1.34e-05	0.000113	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—POMC—autistic disorder	1.33e-05	0.000112	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—XDH—autistic disorder	1.33e-05	0.000112	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—IL2—autistic disorder	1.32e-05	0.000112	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PRKCB—autistic disorder	1.32e-05	0.000112	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MEF2C—autistic disorder	1.32e-05	0.000112	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ADA—autistic disorder	1.31e-05	0.000111	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—STX1A—autistic disorder	1.31e-05	0.000111	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NPAS2—autistic disorder	1.31e-05	0.000111	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CAT—autistic disorder	1.3e-05	0.00011	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—STX1A—autistic disorder	1.3e-05	0.00011	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NPAS2—autistic disorder	1.3e-05	0.00011	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	1.3e-05	0.00011	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ITGB3—autistic disorder	1.29e-05	0.000109	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TCN2—autistic disorder	1.27e-05	0.000107	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AVP—autistic disorder	1.27e-05	0.000107	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PIK3CG—autistic disorder	1.27e-05	0.000107	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IGF2—autistic disorder	1.26e-05	0.000107	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TCN2—autistic disorder	1.26e-05	0.000106	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—APOE—autistic disorder	1.25e-05	0.000105	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	1.24e-05	0.000105	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PLA2G4A—autistic disorder	1.23e-05	0.000104	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GSTM1—autistic disorder	1.23e-05	0.000104	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ADA—autistic disorder	1.21e-05	0.000102	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—POMC—autistic disorder	1.2e-05	0.000102	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR2A—autistic disorder	1.2e-05	0.000102	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL2—autistic disorder	1.2e-05	0.000102	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PRL—autistic disorder	1.2e-05	0.000101	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—RORA—autistic disorder	1.2e-05	0.000101	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ADA—autistic disorder	1.2e-05	0.000101	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PLA2G4A—autistic disorder	1.19e-05	0.000101	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	1.18e-05	0.0001	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GPX1—autistic disorder	1.18e-05	9.96e-05	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—IL2—autistic disorder	1.16e-05	9.8e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MEF2C—autistic disorder	1.16e-05	9.79e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TSC2—autistic disorder	1.14e-05	9.65e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ADRB2—autistic disorder	1.14e-05	9.63e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	1.13e-05	9.59e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ITGB3—autistic disorder	1.13e-05	9.54e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PIK3CG—autistic disorder	1.12e-05	9.51e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MAOB—autistic disorder	1.12e-05	9.49e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—LEP—autistic disorder	1.12e-05	9.44e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—APOE—autistic disorder	1.12e-05	9.44e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—RORA—autistic disorder	1.1e-05	9.32e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—RORA—autistic disorder	1.09e-05	9.23e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—MTHFR—autistic disorder	1.09e-05	9.19e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—POMC—autistic disorder	1.07e-05	9.05e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AVP—autistic disorder	1.07e-05	9.05e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—autistic disorder	1.07e-05	9.03e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IGF2—autistic disorder	1.07e-05	9.01e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR2A—autistic disorder	1.05e-05	8.91e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PRKCB—autistic disorder	1.05e-05	8.91e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL2—autistic disorder	1.05e-05	8.9e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TPH2—autistic disorder	1.04e-05	8.82e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MAOB—autistic disorder	1.03e-05	8.73e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—DPYD—autistic disorder	1.03e-05	8.68e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MAOB—autistic disorder	1.02e-05	8.65e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—APOE—autistic disorder	1.01e-05	8.56e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—APC—autistic disorder	1.01e-05	8.52e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PIK3CG—autistic disorder	1.01e-05	8.52e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PLA2G4A—autistic disorder	1.01e-05	8.51e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TSC2—autistic disorder	1e-05	8.46e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—EGF—autistic disorder	9.97e-06	8.42e-05	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—IL2—autistic disorder	9.8e-06	8.29e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—LEP—autistic disorder	9.8e-06	8.28e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—APOE—autistic disorder	9.8e-06	8.28e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MEF2C—autistic disorder	9.79e-06	8.27e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—autistic disorder	9.75e-06	8.24e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	9.65e-06	8.15e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TPH2—autistic disorder	9.6e-06	8.12e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—POMC—autistic disorder	9.6e-06	8.11e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CACNA1C—autistic disorder	9.55e-06	8.07e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ITGB3—autistic disorder	9.54e-06	8.06e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TPH2—autistic disorder	9.52e-06	8.05e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—DPYD—autistic disorder	9.45e-06	7.98e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—DPYD—autistic disorder	9.37e-06	7.91e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PRKCB—autistic disorder	9.24e-06	7.81e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IGF1—autistic disorder	9.23e-06	7.8e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—MAPK1—autistic disorder	9.19e-06	7.77e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—autistic disorder	9.18e-06	7.76e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3CG—autistic disorder	9.14e-06	7.72e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR2A—autistic disorder	8.91e-06	7.53e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL2—autistic disorder	8.9e-06	7.52e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—APC—autistic disorder	8.84e-06	7.47e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PIK3CG—autistic disorder	8.84e-06	7.47e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	8.8e-06	7.43e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CACNA1C—autistic disorder	8.78e-06	7.42e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SERPINE1—autistic disorder	8.77e-06	7.41e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—EGF—autistic disorder	8.74e-06	7.39e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CACNA1C—autistic disorder	8.71e-06	7.36e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—POMC—autistic disorder	8.7e-06	7.35e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—DHFR—autistic disorder	8.69e-06	7.34e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PTGS2—autistic disorder	8.54e-06	7.22e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TSC2—autistic disorder	8.46e-06	7.15e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—POMC—autistic disorder	8.42e-06	7.11e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	8.37e-06	7.08e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—LEP—autistic disorder	8.28e-06	7e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APOE—autistic disorder	8.28e-06	7e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IGF1—autistic disorder	8.1e-06	6.84e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—MAPK1—autistic disorder	8.06e-06	6.81e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—DHFR—autistic disorder	7.99e-06	6.75e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—DHFR—autistic disorder	7.92e-06	6.69e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PRKCB—autistic disorder	7.81e-06	6.6e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SERPINE1—autistic disorder	7.69e-06	6.5e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APC—autistic disorder	7.47e-06	6.32e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PIK3CG—autistic disorder	7.47e-06	6.32e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PTEN—autistic disorder	7.45e-06	6.29e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—EGF—autistic disorder	7.39e-06	6.24e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HRAS—autistic disorder	7.38e-06	6.23e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	7.32e-06	6.19e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—POMC—autistic disorder	7.11e-06	6.01e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL2—autistic disorder	7.1e-06	6e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL6—autistic disorder	7.06e-06	5.97e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PTGS2—autistic disorder	6.94e-06	5.86e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IGF1—autistic disorder	6.84e-06	5.78e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—MAPK1—autistic disorder	6.81e-06	5.76e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP19A1—autistic disorder	6.8e-06	5.75e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	6.68e-06	5.64e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PTEN—autistic disorder	6.68e-06	5.64e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SERPINE1—autistic disorder	6.5e-06	5.49e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HRAS—autistic disorder	6.47e-06	5.47e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	6.39e-06	5.4e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—COMT—autistic disorder	6.33e-06	5.35e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GSTP1—autistic disorder	6.3e-06	5.32e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MAOA—autistic disorder	6.28e-06	5.31e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP19A1—autistic disorder	6.26e-06	5.29e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL2—autistic disorder	6.22e-06	5.26e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP19A1—autistic disorder	6.2e-06	5.24e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL6—autistic disorder	6.19e-06	5.23e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CAT—autistic disorder	6.13e-06	5.18e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PTEN—autistic disorder	6.05e-06	5.11e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PTEN—autistic disorder	5.86e-06	4.95e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	5.82e-06	4.92e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—COMT—autistic disorder	5.82e-06	4.92e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GSTP1—autistic disorder	5.79e-06	4.89e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PLA2G4A—autistic disorder	5.79e-06	4.89e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GSTM1—autistic disorder	5.79e-06	4.89e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MAOA—autistic disorder	5.78e-06	4.88e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—COMT—autistic disorder	5.77e-06	4.87e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GSTP1—autistic disorder	5.74e-06	4.85e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MAOA—autistic disorder	5.73e-06	4.84e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CAT—autistic disorder	5.64e-06	4.76e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CAT—autistic disorder	5.59e-06	4.72e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GPX1—autistic disorder	5.54e-06	4.68e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HRAS—autistic disorder	5.47e-06	4.62e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MAPK1—autistic disorder	5.43e-06	4.59e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GSTM1—autistic disorder	5.32e-06	4.5e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PLA2G4A—autistic disorder	5.32e-06	4.5e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PLA2G4A—autistic disorder	5.28e-06	4.46e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GSTM1—autistic disorder	5.28e-06	4.46e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL2—autistic disorder	5.26e-06	4.44e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL6—autistic disorder	5.23e-06	4.42e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MTHFR—autistic disorder	5.11e-06	4.32e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GPX1—autistic disorder	5.1e-06	4.31e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GPX1—autistic disorder	5.05e-06	4.27e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PTEN—autistic disorder	4.95e-06	4.18e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MAPK1—autistic disorder	4.76e-06	4.02e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—APOE—autistic disorder	4.76e-06	4.02e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MTHFR—autistic disorder	4.7e-06	3.97e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MTHFR—autistic disorder	4.66e-06	3.94e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—APOE—autistic disorder	4.38e-06	3.7e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HRAS—autistic disorder	4.36e-06	3.68e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—APOE—autistic disorder	4.34e-06	3.67e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3CG—autistic disorder	4.3e-06	3.63e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL6—autistic disorder	4.17e-06	3.53e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—POMC—autistic disorder	4.09e-06	3.46e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MAPK1—autistic disorder	4.02e-06	3.4e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3CG—autistic disorder	3.95e-06	3.34e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3CG—autistic disorder	3.92e-06	3.31e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HRAS—autistic disorder	3.82e-06	3.23e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—POMC—autistic disorder	3.76e-06	3.18e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—POMC—autistic disorder	3.73e-06	3.15e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL6—autistic disorder	3.66e-06	3.09e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTGS2—autistic disorder	3.26e-06	2.76e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HRAS—autistic disorder	3.23e-06	2.73e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL6—autistic disorder	3.09e-06	2.61e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTGS2—autistic disorder	3e-06	2.54e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTGS2—autistic disorder	2.97e-06	2.51e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTEN—autistic disorder	2.84e-06	2.4e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTEN—autistic disorder	2.62e-06	2.21e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTEN—autistic disorder	2.59e-06	2.19e-05	CbGpPWpGaD
